Is 3B Blackbio DX Ltd debt-free?

Yes, 3B Blackbio DX Ltd is debt-free with a debt-to-equity ratio of 0.00.

Home

3B Blackbio DX Ltd

3B Blackbio DX Ltd Financials

3B Blackbio DX Ltd Financial Statement

3B Blackbio DX Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2025	Mar 2025	Dec 2024
Revenue	24.67	27.93	26.44
Operating Expense	8.77	13.56	8.46
Net Profit	12.46	9.24	13.45
Net Profit Margin	50.51	33.08	50.87
Earning Per Share	14.54	10.79	15.70
EBIDTA	15.91	12.85	17.97
Effective Tax Rate	20.25	23.52	23.80

Particulars	Jun 2025
Revenue	24.67
Operating Expense	8.77
Net Profit	12.46
Net Profit Margin	50.51
Earning Per Share	14.54
EBIDTA	15.91
Effective Tax Rate	20.25

3B Blackbio DX Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	90.53	70.72	59.34
Operating Expenses Annual	40.67	35.62	29.76
Operating Profit Annual	64.88	47.43	36.84
Interest Annual	0.10	0.11	0.20
Depreciation	0.86	0.87	0.80
Net Profit Annual	47.56	34.21	26.42
Tax Annual	16.37	12.23	9.42

Particulars	Mar 2025
Total Revenue Annual	90.53
Operating Expenses Annual	40.67
Operating Profit Annual	64.88
Interest Annual	0.10
Depreciation	0.86
Net Profit Annual	47.56
Tax Annual	16.37

3B Blackbio DX Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	54.88	50.35	39.89
Cash Flow from Operations	44.47	28.47	21.16
Cash Flow from Investing	-33.64	-20.32	-7.80
Cash Flow from Financing	-3.07	-3.62	-2.89
Cash Flow at the End	62.63	54.88	50.35

Particulars	Mar 2025
Cash Flow at the Beginning	54.88
Cash Flow from Operations	44.47
Cash Flow from Investing	-33.64
Cash Flow from Financing	-3.07
Cash Flow at the End	62.63

3B Blackbio DX Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	71.68	67.05	62.08
PBIT Margin (%)	70.73	65.82	60.73
PBT Margin (%)	-636.55	-532.57	-242.94
Net PROFIT Margin (%)	52.54	48.37	44.52
Return On Networth / Equity (%)	19	16.14	24.01
Return On Networth /Employed (%)	25.53	21.82	32.09
Return On Assets (%)	18.91	15.96	23.60
Total Debt / Equity (X)	TBA	0.01	0.02
Asset Turnover Ratio (%)	0.36	0.33	0.53

Particulars	Mar 2025
PBDIT Margin (%)	71.68
PBIT Margin (%)	70.73
PBT Margin (%)	-636.55
Net PROFIT Margin (%)	52.54
Return On Networth / Equity (%)	19
Return On Networth /Employed (%)	25.53
Return On Assets (%)	18.91
Total Debt / Equity (X)	TBA
Asset Turnover Ratio (%)	0.36

3B Blackbio DX Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	6.37	6.53	6.79
Total Current Assets Annual	124.05	115.59	104.46
Non Current Assets Annual	173.07	134.23	109.21
Total Shareholders Funds Annual	272.79	227.78	196.09
Total Assets Annual	297.12	249.82	213.67

Particulars	Mar 2025
Fixed Assets Annual	6.37
Total Current Assets Annual	124.05
Non Current Assets Annual	173.07
Total Shareholders Funds Annual	272.79
Total Assets Annual	297.12

3B Blackbio DX Ltd Earning Calls

EPS (INR)

Expected

14.69

Reported

14.76

Surprise

0.48%

Mar 2025

EPS beaten by 0.48%

Dec 2024

EPS beaten by -4.29%

Sep 2024

EPS beaten by 0.70%

Dividend Pages

PE Ratio

FAQS on 3B Blackbio DX Ltd Financials

As of Sep 30, 2025, 3B Blackbio DX Ltd has a market capitalization of 1,387.60 Cr. Value Research classifies it as a Small-Cap company.

Yes, 3B Blackbio DX Ltd is with a debt-to-equity ratio of 0.00.

In FY 2024 , 3B Blackbio DX Ltd recorded a total revenue of approximately 90.53 Cr marking a significant milestone in the company's financial performance.

3B Blackbio DX Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.7% and 0.2% annually, respectively..

3B Blackbio DX Ltd's current PE ratio is 29.18.

3B Blackbio DX Ltd's ROCE averaged 20.7% from the FY ending March 2023 to 2025, with a median of 20.4%. It peaked at 23.4% in March 2025, reflecting strong capital efficiency over the period..

3B Blackbio DX Ltd's latest EBIT is Rs. 64.03 Cr, surpassing the average EBIT of Rs. 48.87 Cr over the 5 years..